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THE REGRESSION of advanced breast
cancer which can follow ovarian ablation is
believed to be due to reduction in the
levels of circulating oestrogen. The bene-
fit which may follow adrenalectomy in
oophorectomized and in post-menopausal
women cannot be explained on a similar
premise. In post-menopausal women
plasma oestrogens are already low
(England et al., 1974) and the adrenal
cortex secretes only trace amounts of
oestrogen. The main sex hormones secre-
ted by the adrenal cortex are C19 steroids
(Cameron et al., 1969) which we and
others have shown to be metabolized by
breast tumours (Adams and Wong, 1968;
Jones et al., 1970; Jenkins and Ash
1972; Miller et al., 1973). Recently we
gave unequivocal evidence that the C19
steroid, testosterone could be utilized by
a human breast cancer to synthesize
oestradiol-17,8 (Miller and Forrest, 1974).
The aim of this study was to determine
whether this effect was reproducible in
other tumours.
MATERIALS AND METHOI)S
Patients.-Thirteen patients with proved
cancer of the breast were studied. Eight
subjects were at least 5 years postmenopausal,
a further 2 were less than 5 years postmeno-
pausal and 2 more were experiencing regular
menstrual periods at the time ofinvestigation.
The remaining patient had been oophorecto-
mized 2 years before the study.
Tumour processing and incubation.-
Following excision, the tumours (11 primary
and 2 secondary recurrences from the chest
wall) were put on ice in the operating theatre.
Sufficient tissue was removed by a pathologist
for histological diagnosis and the remainder
ofthe tumour was finely sliced and incubated
for 2 h at 37°C in Krebs Ringer phosphate
buffer pH 7-4 (10 ml/g tissue), containing an
NADPH generating system and 45 ,uCi 7W3H
testosterone. The metabolism of testosterone
was then determined by measuring the per-
centage ofincorporationof3H intothevarious
purified metabolites. Details of the metho-
dology used for steroid purification, charac-
terization by chemical derivatives and
measurement have been described previously
(Miller, Forrest and Hamilton, 1974). Iden-
tification of oestradiol-17/ fractions was
basedonthefollowingcriteria: (a)thefractions
on acetylation and methylation formed com-
pounds which, on thin layer chromatography,
moved with the same mobility as authentic
oestradiol diacetate and oestradiol-3-methyl
ether respectively; (b) consistent specific
radioactivity was maintained throughout
derivative formation.
RESULTS
The percentage radioactivity found in
the various metabolites investigated is
shown in Table I.
All tumours metabolized testosterone
but with considerable variation (17-54% %).
The presence of 5a reductase activity was
demonstrated in all tumours and both 5ca
dihydrotestosterone and 5Lx androstanediol
were identified as metabolites. The level
of production of 5ac dihydrotestosterone
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TABLE I.-Metabolism of 7x3H Testosterone by Human Breast Carcinomata
0h Metabolism % Conversion to
5a Dihydrotestosterone 5a Androstanediol A 4 Androstenedione Oestradiol-17fl
1-67 0-85 4-71 0 37
1-93 0-69 6-76 0-22
0-65 0*13 38-49 0-07
2-79 1-18 7 83 0-06
037 009 0-39 005
0-41 009 2-03 004
0-72 0-16 6-90 neg?
0-58 0-21 3-84 neg? 2-61 1-18 2-91 neg?
0-91 0-38 4-83 neg? 3:04 1-50 0-60 0
3*04 1-50 0-60 0
0 44 0-15 0-65 0
neg?=low inconsistent specific radioactivity.
TABLE II.-Evidence for the Identification of Oestradiol 17/3
Derivative
E.C. Oestradiol free
Oestradiol diacetate
Oestradiol methyl ether
I.C. Oestradiol free
Oestradiol diacetate
Oestradiol methyl ether
E.Cr. Oestradiol free
Oestradiol diacetate
Oestradiol methyl ether
A.R. Oestradiol free
Oestradiol diacetate
Oestradiol methyl ether
E.S. Oestradiol free
Oestradiol diacetate
Oestradiol methyl ether
CMcD Oestradiol free
Oestradiol diacetate
Oestradiol methyl ether
taniediol. All tumours converted testos-
terone to A4 androstenedione and, in
most, this steroid represented the single
greatest metabolite identified.
Unequivocal evidence (Table II) for
the synthesis of oestradiol-17,/ was found
in 6 tumours, in 2 of which the amounts
were substantial. In 7 tumours oestra-
diol-l 7,/ was not identified. Although in
4 of these small amounts of radioactive
label were incorporated in the crude
oestradiol fraction, consistent specific
radioactivity was not obtained in the
derivatives.
COMMENT
These findings confirm that all human
breast cancers can metabolize C19 steroids.
Specific activity
d/min/nmol
211
225
229
126
118
121
44-7
45-5
41-6
35-3
33-8
34-9
31-7
31 8
29-2
17-8
19-1
18 2
% Conversion
0 37
0C22
0-08
0-06
0 05
0 04
Furthermore, all tumours studied had
5ac reductase activity and were able to
convert testosterone into its 2 active 5cc
reduction products, 5x dihydrotestos-
terone and 5z androstanediol.
In contradistinction, not all tumours
could synthesize oestradiol-17/3 and we
conclude that the possession of the aro-
matizing system is specific to certain types
of tumour. To date, we have not un-
covered any particular difference between
those tumours which have oestradiol
synthesizing capacity and those which do
not.
Since biologically approximately half
of all human breast cancers do show some
degree of hormone dependence and one-
third markedly so, it is tempting to believe
EC
JC
E.Cr
A.R.
ES
CMcD
CR
GAT
G.A.
AIAIcN
J.AM.
MR
JR
17-03
39-35
53-79
24-55
24-48
19-92
28-94
26-93
33-36
29-59
27-66
27-66
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that the possession ofaromatizing enzymes
may be of importance in this regard. In
this event, the tumours which were capa-
ble of transforming C19 steroid into oes-
trogen could be those which are dependent
on the adrenal cortical source of C19
steroids.
We have already suggested that the
beneficial effects of adrenalectomy and
hypophysectomy could be due to reduc-
tion of circulating C19 precursor steroids
such as DHA sulphate (Miller and For-
rest, 1974). The results we now report
are further evidence of such a possibility.
Studies are now in progress to deter-
mine the relationship of possession of this
synthetic pathway to oestrogen receptor
activity and to the clinical response to
adrenalectomy and hypophysectomy.
The authors wish to thank the Cancer
Research Campaign for Grant No. SP
1256 supporting this work.
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